[Diastolic dysfunction in liver cirrhosis]

L Ratti1, E Redaelli, C Guidi

  • 1Clinica Medica, Università Milano-Bicocca, Azienda Ospedaliera San Gerardo, Monza, Milán, Italia.

Gastroenterologia Y Hepatologia
|December 24, 2005
PubMed

Insights

Cirrhotic cardiomyopathy, characterized by diastolic dysfunction, affects liver disease patients. Understanding this cardiac issue is crucial for managing liver cirrhosis complications and reducing cardiovascular risk.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Hyperdynamic circulation is a known complication of liver cirrhosis.
  • Early studies suggested alcoholic cardiomyopathy, but recent research highlights broader cardiac dysfunction in post-viral cirrhosis.
  • Neurohumoral hyperactivity and cardiodepressant substances contribute to cardiac changes in advanced liver disease.

Purpose of the Study:

  • To establish the clinical significance of diastolic dysfunction in liver cirrhosis.
  • To introduce and define the concept of "cirrhotic cardiomyopathy".
  • To improve understanding of cardiovascular risks associated with liver cirrhosis management.

Main Methods:

  • Echocardiography used to detect left ventricular diastolic dysfunction and altered transmitral flow patterns.
  • Review of existing studies on cardiac function in cirrhotic patients.
  • Clinical observation of diastolic dysfunction, especially in decompensated cirrhosis.

Main Results:

  • Clinically insignificant diastolic cardiac function has been observed.
  • Lack of left ventricular relaxation and altered transmitral flow are characteristic findings.
  • Growing evidence points to diastolic dysfunction as a significant issue in liver cirrhosis.

Conclusions:

  • Cirrhotic cardiomyopathy is a clinically relevant entity in liver cirrhosis.
  • Understanding cirrhotic cardiomyopathy can help mitigate cardiovascular risks during procedures like paracentesis and liver transplantation.
  • Further research into cirrhotic cardiomyopathy is needed to improve patient outcomes.

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...